{
    "name": "cycloserine",
    "comment": "Rx",
    "other_names": [
        "Seromycin"
    ],
    "classes": [
        "Antitubercular Agents"
    ],
    "source": "https://reference.medscape.com/drug/seromycin-cycloserine-342660",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: enters breast milk; safe"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: enters breast milk; safe"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity",
                "Alcohol use",
                "Renal dysfunction, severe",
                "History of seizure disorder, mental depression, severe anxiety or psychosis"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Caution in patients with history of alcoholism (may increase seizures), anemia, impaired hepatic/renal function",
                "CNS toxicity (depression, seizures, psychosis) may occur",
                "Prolonged use may result in fungal or bacterial superinfection (C. difficile-associated diarrhea)"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ethionamide",
            "description": {
                "common": "ethionamide, cycloserine.\nEither increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Enhanced CNS toxicity; risk of seizure."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "isoniazid",
            "description": {
                "common": "isoniazid increases toxicity of cycloserine by decreasing metabolism. Use Caution/Monitor. Enhanced CNS toxicity; risk of seizure."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "sodium picosulfate/magnesium oxide/anhydrous citric acid",
            "description": {
                "common": "cycloserine decreases effects of sodium picosulfate/magnesium oxide/anhydrous citric acid by altering metabolism. Use Caution/Monitor. Coadministration with antibiotics decreases efficacy by altering colonic bacterial flora needed to convert sodium picosulfate to active drug."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Confusion",
            "percent": null
        },
        {
            "name": "Restlessness",
            "percent": null
        },
        {
            "name": "Drowsiness",
            "percent": null
        },
        {
            "name": "Vertigo",
            "percent": null
        },
        {
            "name": "Cardiac arrhythmia",
            "percent": null
        },
        {
            "name": "Folate deficiency",
            "percent": null
        },
        {
            "name": "Hyperreflexia",
            "percent": null
        },
        {
            "name": "Dysarthria",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Coma",
            "percent": null
        },
        {
            "name": "Liver enzymes increased",
            "percent": null
        },
        {
            "name": "Somnolence",
            "percent": null
        },
        {
            "name": "Paresis",
            "percent": null
        },
        {
            "name": "Seizure",
            "percent": null
        },
        {
            "name": "Heart failure",
            "percent": null
        }
    ]
}